NCT00757263 Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom Status UNKNOWN Phase N/A
NCT00753740 Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients. Status WITHDRAWN Phase PHASE2
NCT00753545 Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00753480 A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Status SUSPENDED Phase PHASE1
NCT00751205 Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC) Status COMPLETED Phase PHASE2
NCT00750386 Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas Status COMPLETED Phase PHASE1/PHASE2
NCT00748527 Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Status TERMINATED Phase PHASE2
NCT00746018 Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy Status COMPLETED Phase NA
NCT00744718 Bevacizumab and Carboplatin for Patients With Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00739661 A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission Status COMPLETED Phase PHASE2
NCT00738699 An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer Status TERMINATED Phase PHASE2
NCT00735150 Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk Status COMPLETED Phase N/A
NCT00726635 The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies Status UNKNOWN Phase PHASE3
NCT00722592 Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04) Status COMPLETED Phase PHASE2
NCT00722228 Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT00720096 Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan Status TERMINATED Phase NA
NCT00716976 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Status COMPLETED Phase PHASE3